Welcome to LookChem.com Sign In|Join Free
  • or
"3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrole-2,5-dione" is a complex organic compound with a unique molecular structure. It features a pyrrole-2,5-dione core, which is a heterocyclic compound with two carbonyl groups and a pyrrole ring. The molecule is further characterized by the presence of a 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl group, which is a fused ring system incorporating a pyrroloquinoline moiety, and a 1H-indol-3-yl group, indicating the presence of an indole ring with a hydrogen atom at the 1-position and a substituent at the 3-position. 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrole-2,5-dione is likely to be of interest in the field of medicinal chemistry or materials science due to its potential biological activities or electronic properties, although specific applications or properties are not detailed in the provided information.

345261-20-3

Post Buying Request

345261-20-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

345261-20-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 345261-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,5,2,6 and 1 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 345261-20:
(8*3)+(7*4)+(6*5)+(5*2)+(4*6)+(3*1)+(2*2)+(1*0)=123
123 % 10 = 3
So 345261-20-3 is a valid CAS Registry Number.

345261-20-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-y l)-1H-pyrrole-2,5-dione

1.2 Other means of identification

Product number -
Other names 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrole-2,5-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:345261-20-3 SDS

345261-20-3Relevant academic research and scientific papers

1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors

Al-Awar, Rima S.,Ray, James E.,Hecker, Kyle A.,Huang, Jianping,Waid, Philip P.,Shih, Chuan,Brooks, Harold B.,Spencer, Charles D.,Watkins, Scott A.,Patel, Bharvin R.,Stamm, Nancy B.,Ogg, Catherine A.,Schultz, Richard M.,Considine, Eileen L.,Faul, Margaret M.,Sullivan, Kevin A.,Kolis, Stanley P.,Grutsch, John L.,Joseph, Sajan

, p. 3217 - 3220 (2004)

The synthesis and kinase inhibitory activity of a series of novel 1,7-annulated indolocarbazoles 6 and 16 is described. These compounds exhibited potent inhibitory activity against cyclin-dependent kinase 4 and good antiproliferative activity in a human colon carcinoma cell line.

COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

-

, (2015/12/23)

The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or a pyrroloquinolinyl-pyrrolidine-2,5-dione compound in combination with a therapeutically effective amount of a second anti-proliferative agent.

Highly Pure Pyrroloquinolinyl-Pyrrole-2,5-Dione and Pyrroloquinolinyl-Pyrrolidine-2,5-Dione and Methods of Preparing Same

-

Paragraph 0125; 0126; 0127, (2013/11/05)

The present invention relates to highly-pure pyrroloquinolinyl-pyrrole-2,5-dione and pyrroloquinolinyl-pyrrolidine-2,5-dione, for example, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione, 3-(5,6-dihydro-4H-pyrrolo[

Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same

-

Page/Page column 24-25, (2011/07/08)

The present invention relates to a form 1 and form 2 polymorph of (?)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione. The present invention also relates to (?)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinol

MELEIMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

-

Page/Page column 53, (2008/06/13)

The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 345261-20-3